Clinical Research

Correlation of novel anthropometric indicators with long⁃term prognosis in patients with acute myocardial infarction

  • Kaiyang WANG ,
  • Jing TAO ,
  • Tingting WU ,
  • Jiahui YONG ,
  • Guoqing LI ,
  • Xiang XIE ,
  • Yining. YANG
Expand
  • *.Department of Cardiology,Xinjiang Uygur Autonomous Region People's Hospital,Urumqi 830000,Xinjiang,China
    *.Xinjiang Key Laboratory of Cardiovascular Homeostasis and Regenerative Medicine,Urumqi 830000,Xinjiang,China

Received date: 2024-05-18

  Online published: 2024-11-19

Abstract

Objective To explore the predictive value of novel anthropometric indicators for the long-term prognosis in patients with acute myocardial infarction (AMI). Methods A total of 712 patients diagnosed with AMI in the People's Hospital of Xinjiang Uygur Autonomous Region from January 2018 to December 2019 were selected as research subjects, and divided into an event group and a non-event group according to whether major cardiovascular adverse events (MACEs) occurred during the period of follow-up. Gensini score was used to quantitatively assess the degree of coronary artery stenosis. Spearman correlation analysis was used to explore the correlation between the new anthropometric indicators and Gensini score. Receiver operating characteristic (ROC) curve was used to evaluate the ability of new anthropometric indicators to predict MACEs, and the patients were grouped according to the optimal cut-off value. Kaplan-Meier curve was used to analyze the survival difference between the groups. Multivariate Cox regression was used to analyze the independent risk factors of MACEs. Results During a median follow-up of 27(20,39)months, a total of 125 patients developed MACEs. As compared with those in the non-event group, the patients in the event group had a higher proportion of hypertension, diabetes and abdominal obesity, higher HbA1c and FBG levels, and longer body weight and waist circumference. The LAP index, CMI index, BRI index and Gensini score were significantly increased, and the differences were statistically significant (P ? 0.05). Spearman correlation analysis showed that LAP index, CMI index and BRI index were positively correlated with Gensini score (r = 0.233, 0.126, 0.272, P < 0.001). ROC curve analysis showed that the AUC of LAP index, CMI index, VAI index, BRI index and ABSI index were 0.745, 0.640, 0.490, 0.874 and 0.506 respectively; Kaplan-Meier curve analysis showed that the cumulative incidence of MACEs in LAP index, CMI index and BRI index was significantly increased in the high-value group (Log-rank test, P ? 0.05). The results of multivariate Cox regression analysis after adjusting confounding showed that CMI index (HR = 1.430, 95%CI: 1.049 ~ 1.952, P = 0.024) and BRI index (HR = 1.332, 95%CI: 1.234 ~ 1.439, P ? 0.001)were independent risk factors for MACEs. Conclusions CMI index and BRI index of new anthropometric indicators are independent risk factors for long-term prognosis in patients with AMI.

Cite this article

Kaiyang WANG , Jing TAO , Tingting WU , Jiahui YONG , Guoqing LI , Xiang XIE , Yining. YANG . Correlation of novel anthropometric indicators with long⁃term prognosis in patients with acute myocardial infarction[J]. The Journal of Practical Medicine, 2024 , 40(21) : 3040 -3046 . DOI: 10.3969/j.issn.1006-5725.2024.21.013

References

1 LAWTON J S, TAMIS-HOLLAND J E, BANGALORE S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2022, 145(3): e4-e17. doi:10.1161/cir.0000000000001061
2 中国心血管健康与疾病报告编写组, 胡盛寿. 中国心血管健康与疾病报告2022概要[J]. 中国循环杂志, 2023, 38(6): 583-612. doi:10.3969/j.issn.1000-3614.2023.06.001
3 YUAN S, BRUZELIUS M, XIONG Y, et al. Overall and abdominal obesity in relation to venous thromboembolism[J]. J Thromb Haemost, 2021, 19(2): 460-469. doi:10.1111/jth.15168
4 秦叶叶, 李燕, 郑路, 等. 评估内脏型肥胖的新型人体测量学指标研究进展[J]. 国际内分泌代谢杂志, 2021, 41(3):207-211.
5 BYRNE R A, ROSSELLO X, COUGHLAN J J, et al. 2023 ESC Guidelines for the management of acute coronary syndromes[J]. Eur Heart J, 2023, 44(38): 3720-3826.
6 WANG K Y, ZHENG Y Y, WU T T, et al. Predictive Value of Gensini Score in the Long-Term Outcomes of Patients With Coronary Artery Disease Who Underwent PCI[J]. Front Cardiovasc Med, 2021, 8: 778615. doi:10.3389/fcvm.2021.778615
7 REYNOLDS H R, SHAW L J, MIN J K, et al. Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity[J]. Circulation, 2021,144(13):1024-1038.
8 MANCIA G, KREUTZ R, BRUNSTR?M M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) [J]. J Hypertens, 2023, 41(12): 1874-2071.
9 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)(上)[J]. 中国实用内科杂志, 2021, 41(8):668-695.
10 中华医学会心血管病学分会高血压学组, 中华心血管病杂志编辑委员会. 中国高血压患者血压血脂综合管理的专家共识[J]. 中华心血管病杂志, 2021, 49(6): 554-563.
11 中国营养学会肥胖防控分会, 中国营养学会临床营养分会, 中华预防医学会行为健康分会, 等. 中国居民肥胖防治专家共识[J]. 中华流行病学杂志, 2022, 43(5): 609-626.
12 中国营养学会肥胖防控分会, 中国营养学会临床营养分会, 中华预防医学会行为健康分会, 等. 中国居民肥胖防治专家共识[J]. 中国预防医学杂志, 2022, 23(5): 321-339.
13 WANG Y, ZHAO L, GAO L, et al. Health policy and public health implications of obesity in China [J]. Lancet Diabetes Endocrinol, 2021, 9(7): 446-461. doi:10.1016/s2213-8587(21)00118-2
14 HOTAMISLIGIL G S. Inflammation and metabolic disorders [J]. Nature, 2006, 444(7121): 860-867. doi:10.1038/nature05485
15 CHEN Z, IONA A, PARISH S, et al. Adiposity and risk of ischaemic and haemorrhagic stroke in 0.5 million Chinese men and women: A prospective cohort study[J]. Lancet Glob Health, 2018, 6(6): e630–e640.
16 李岳航, 王愿, 李义帅, 等. 内脏脂肪在肺癌中的研究进展[J].实用医学杂志,2022, 38(10):1292-1297.
17 XU C, GUO Y, ZHANG S, et al. Visceral adiposity index and the risk of heart failure, late-life cardiac structure, and function in ARIC study[J]. Eur J Prev Cardiol, 2023, 30(12): 1182-1192. doi:10.1093/eurjpc/zwad099
18 伍朝春, 黄政德, 庞羽, 等. 肥胖症多学科协作诊疗模式研究进展[J].实用医学杂志,2023,39(12):1588-1592. doi:10.3969/j.issn.1006-5725.2023.12.022
19 KYROU I, PANAGIOTAKOS D B, KOULI G M, et al. Lipid accumulation product in relation to 10-year cardiovascular disease incidence in Caucasian adults: The ATTICA study[J]. Atherosclerosis, 2018, 279: 10-16. doi:10.1016/j.atherosclerosis.2018.10.015
20 WAKABAYASHI I, DAIMON T. The "cardiometabolic index" as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus[J]. Clin Chim Acta, 2015, 438: 274-278. doi:10.1016/j.cca.2014.08.042
21 SHI W R, WANG H Y, CHEN S, et al. Estimate of prevalent diabetes from cardiometabolic index in general Chinese population: a community-based study[J]. Lipids Health Dis, 2018, 17(1):236. doi:10.1186/s12944-018-0886-2
22 THOMAS D M, BREDLAU C, BOSY-WESTPHAL A, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model[J]. Obesity (Silver Spring), 2013, 21(11): 2264-2271. doi:10.1002/oby.20408
23 RICO-MARTíN S, CALDERóN-GARCíA J F, SáNCHEZ-REY P, et al. Effectiveness of body roundness index in predicting metabolic syndrome: A systematic review and meta-analysis[J]. Obes Rev, 2020, 21(7): e13023. doi:10.1111/obr.13023
24 KRAKAUER N Y, KRAKAUER J C. A new body shape index predicts mortality hazard independently of body mass index[J]. PLoS One, 2012, 7(7): e39504. doi:10.1371/journal.pone.0039504
25 JI M, ZHANG S, AN R. Effectiveness of A Body Shape Index (ABSI) in predicting chronic diseases and mortality: a systematic review and meta-analysis[J]. Obes Rev, 2018, 19(5): 737-759. doi:10.1111/obr.12666
Outlines

/